|
2024
|
Invention
|
Humanized m-csf mice.
Genetically modified mice comprising a nucleic acid sequence encoding a hu... |
|
|
Invention
|
Genetically modified non-human animals and methods of use thereof.
The invention relates general... |
|
2023
|
Invention
|
Genetically modified non-human animals and methods of use thereof.
Genetically modified non-huma... |
|
|
Invention
|
Genetically modified non-human animals expressing human epo.
Genetically modified non-human anim... |
|
|
Invention
|
Cross-specific antibodies, uses and methods for discovery thereof. The invention relates to antib... |
|
2020
|
Invention
|
Genetically modified non-human animals and methods of use thereof. Genetically modified non-human... |
|
2019
|
Invention
|
Genetically modified non-human animals expressing human epo. Genetically modified non-human anima... |
|
|
Invention
|
Genetically modified non-human animals and methods of use thereof. The invention relates generall... |
|
|
Invention
|
Genetically modified mice and engraftment. M. tuberculosis is described. A mouse that models a hu... |
|
2017
|
Invention
|
Humanized m-csf mice. Genetically modified mice comprising a nucleic acid sequence encoding a hum... |
|
2016
|
Invention
|
Humanized sirpa-il15 knockin mice and methods of use thereof. Genetically modified non-human anim... |
|
2013
|
Invention
|
Genetically modified mice which express human cytokines and methods of use thereof, including eng... |
|
2010
|
Invention
|
Genetically modified mice and engraftment. A mouse with a humanization of the mIL-3 gene and the ... |
|
|
Invention
|
Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo)... |
